Condition
Squamous Cell Carcinoma in Situ
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Completed2
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05381597Phase 2Recruiting
5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer
NCT04844983Phase 2CompletedPrimary
A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC
NCT04695015Unknown
Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm
NCT01245972Not ApplicableCompleted
Pilot Study of PDL to Treat BCC and SCCIS
Showing all 4 trials